查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1886012

全球心臟幫浦市場

Heart Pump Devices
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計2030年，全球心臟輔助設備市場規模將達85億美元。

全球心臟輔助設備市場規模在2024年估計為32億美元，預計到2030年將達到85億美元，在分析期（2024-2030年）內複合年成長率（CAGR）為17.4%。本報告分析的細分市場之一－心室輔助設備（VAD）預計將以19.1%的複合年成長率成長，並在分析期結束時達到51億美元。主動脈內球囊反搏幫浦（IABP）細分市場預計在分析期間內將以14.6%的複合年成長率成長。

美國市場規模估計為8.846億美元，而中國市場預計將以16.4%的複合年成長率成長。

預計到2024年，美國心臟幫浦設備市場規模將達到8.846億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到13億美元，在2024年至2030年的分析期間內，複合年成長率（CAGR）將達到16.4%。其他值得關注的區域市場包括日本和加拿大，預計在分析期內，這兩個市場的複合年成長率將分別達到15.7%和14.2%。在歐洲，德國的複合年成長率預計將達到約11.2%。

全球心臟幫浦設備市場－主要市場趨勢與促進因素概述

為什麼心臟幫浦在治療晚期心臟衰竭、輔助心血管手術和提高患者存活率方面變得越來越重要？

心臟幫浦對於治療晚期心臟衰竭、輔助心血管手術以及提高患者存活率至關重要。那麼，為什麼這些裝置在今天如此重要？隨著全球心臟衰竭盛行率的不斷上升，心臟泵，例如左心室輔助裝置（LVAD）和經關節人工心臟（TAH），為那些對藥物或常規治療方法不再有效的患者提供了挽救生命的解決方案。這些裝置對於支持或完全替代衰竭的心臟至關重要，它們可以幫助心臟更有效地泵血，並確保重要器官持續獲得充足的氧氣和營養。對於許多末期心臟衰竭患者而言，心臟幫浦是他們在等待心臟移植期間維持生命的唯一現實選擇，或在無法進行心臟移植時作為長期替代方案。

除了用於治療心臟衰竭外，心臟幫浦在支持接受高風險心血管手術的患者方面也發揮著至關重要的作用。在這些手術過程中，心臟幫浦提供的臨時機械循環支援可以維持血液流動，並降低術中和術後併發症的風險。此外，當心臟本身無法泵出足夠的血液時，這些裝置也擴大用於穩定從心肌梗塞或心源性休克中恢復的嚴重患者。

此外，心臟泵血裝置能夠顯著改善心臟衰竭患者的生活品質，減輕疲勞、呼吸困難和體液儲存等症狀。透過輔助心臟功能，患者可以更輕鬆地進行日常活動，從而改善身心健康。

科技進步與創新如何讓心臟輔助設備更有效率、更安全、更耐用？

技術進步和創新顯著提高了心臟泵血裝置的效率、安全性和耐用性，使其成為治療方法心臟衰竭患者更可靠、更有效的方案。其中一項最具影響力的創新是開發出更小巧、更耐用、創傷更小的左心室輔助裝置（LVAD）。這些新一代LVAD旨在降低植入手術風險，並改善患者預後。小型化技術的創新使其適用於更廣泛的患者群體，包括那些因體型原因而仿單標示外使用舊型號裝置的患者。此外，小型化也減少了大規模的必要性，從而降低了感染疾病和血栓等併發症。

心臟幫浦技術的另一個重要進展是能源效率和電池壽命的提升。早期的心臟幫浦設備需要患者隨身攜帶外接電池，這限制了患者的活動能力和便利性。如今，先進的電池技術提供了持久耐用的攜帶式電源，減少了頻繁更換和充電的需求。一些設備也正在探索無線充電技術，這將徹底消除對外部電源線的依賴，進一步提升患者的生活品質。這些改進使心臟泵設備更加實用、創傷更小，讓患者能夠擁有更自由和獨立的生活。

人工智慧 (AI) 與數據分析的整合是心臟泵設備的另一項關鍵創新。 AI 驅動的監測系統持續追蹤設備效能和病患生理參數，以便及早發現潛在問題，並在出現故障或劣化徵兆時向醫護人員發出警報。這些智慧系統有助於最佳化設備設置，進行即時調整，確保心臟泵以最佳效率運作。 AI 演算法甚至可以預測患者何時需要醫療干預，從而改善長期療效並降低併發症風險。

生物相容性材料是心臟泵裝置領域另一個取得顯著進展的面向。這些裝置中使用的新型材料降低了血栓症和感染的風險，而血栓和感染是心臟泵常見的併發症。使用先進的塗層和模擬生物組織的材料可以最大限度地減少免疫系統對裝置的反應，從而減少對抗凝血劑和其他藥物的需求。這不僅提高了患者的安全性，而且透過減少磨損延長了裝置的使用壽命。

遠端監測功能正在改變心臟幫浦設備的管理方式。如今，透過互聯的醫療平台，可以對植入心臟幫浦的患者進行遠端監測，使醫護人員能夠即時追蹤設備性能和患者健康指標。這有助於及早發現潛在問題，減少患者頻繁就醫的次數，同時也讓患者和醫護人員都感到安心。此外，遠端監測技術的進步意味著患者不再需要頻繁住院，並且更有可能獲得個人化護理和治療方案的調整。

為什麼心臟輔助裝置對降低心臟衰竭患者的再入院率、延長平均壽命和提高生活品質如此重要？

由於心臟泵裝置為患有嚴重心臟疾病的患者提供了長期解決方案，因此對於降低再入院率、延長平均壽命和提高心臟衰竭患者的生活品質至關重要。心臟幫浦裝置如此寶貴的原因之一是其能夠減少慢性心臟衰竭患者的再入院次數。心臟衰竭的特徵通常是症狀反覆出現，隨著心臟泵血能力的下降，會導致患者反覆住院。心臟輔助裝置透過持續支持心臟功能、穩定患者病情並減少頻繁醫療干預的需求來緩解這一問題。這不僅提高了患者的生活品質，而且透過減少對急診和醫院資源的需求，減輕了醫療保健系統的壓力。

心臟輔助裝置的另一個主要益處是平均壽命。若不進行先進治療方法，末期心臟衰竭患者的預期平均壽命通常只有幾個月到幾年。心臟輔助裝置，特別是左心室輔助裝置（LVAD），能夠支持等待心臟移植患者的心臟功能，並且已被證明在移植不可行的情況下，作為長期治療手段，能夠顯著延長患者的生存期。在許多情況下，植入LVAD的患者可以依靠該裝置存活數年，從而有時間接受其他治療並維持更高的生活品質。

改善心臟衰竭患者的生活品質是心臟輔助裝置的關鍵好處之一。心臟衰竭會嚴重限制患者的日常生活能力，導致疲勞、呼吸困難和參與體育活動的能力下降。心臟幫浦裝置透過改善血液循環來緩解這些症狀，使患者恢復體力和精力。這有助於他們擁有更積極的生活方式、參與社交活動，並增強獨立感。許多接受心臟幫浦裝置植入的患者表示，植入後的身心健康狀況都顯著改善了。

心臟幫浦也為不適合心臟移植的患者提供了一種替代方案。有些患者由於年齡、合併症以及捐贈心臟的可用性等多種原因不適合進行心臟移植。在這種情況下，心臟輔助裝置可以作為長期解決方案，為心臟提供機械支持，使患者能夠活得更長久、更健康。這對於老年患者以及那些患有其他疾病而難以符合移植條件的患者來說尤其重要。

除了用於治療心臟衰竭外，心臟幫浦還有助於預防其他心血管疾病相關的併發症，例如心源性休克和心肌梗塞。透過在這些緊急情況下提供機械循環支持，心臟幫浦可以穩定患者病情，防止心臟進一步受損，從而提高整體存活率並降低長期併發症的風險。

哪些因素正在推動心臟幫浦設備市場的成長？

推動心臟幫浦設備市場快速成長的關鍵因素包括心臟衰竭衰竭盛行率的上升、心臟幫浦技術的進步、全球人口老化以及對機械循環支援需求的不斷成長。其中一個主要促進因素是全球心臟衰竭患者數量的增加。隨著人口老化以及肥胖、高血壓和糖尿病等文明病的盛行率上升，心臟衰竭患者的數量正在穩步成長。這顯著增加了對心臟幫浦等先進治療方法的需求，這些療法能夠為那些對藥物治療或微創治療不再有效的患者提供有效且長期的解決方案。

心臟泵技術的進步是推動市場成長的另一個主要因素。更小巧、更耐用、創傷更小的心臟泵的研發，使得更多患者能夠使用心臟泵，包括輕度心臟衰竭患者以及不仿單標示外傳統心臟泵的患者。這些技術進步也帶來了更好的治療效果、更少的併發症和更高的存活率，從而推動了心臟幫浦在全球醫療系統中的應用。

全球人口老化也是心臟幫浦設備市場成長的重要推手。隨著預期壽命的不斷延長，包括心臟衰竭在內的與老齡化相關的心血管疾病的發生率也在上升。老年患者更容易患上削弱心臟功能的疾病，因此他們是心臟泵設備的理想適應症。預計未來幾十年老年人口數量將顯著成長，因此，作為治療老齡化心臟衰竭的一種選擇，心臟泵的需求預計將會成長。

對機械循環支援裝置（包括短期和長期使用）日益成長的需求也推動了市場成長。心臟幫浦裝置擴大應用於加護治療環境中，例如高風險心血管手術期間以及心肌梗塞和心源性休克復健期。它們能夠穩定患者病情並幫助其康復，使其成為心臟病專家和心臟外科醫生的寶貴工具，進一步推動了其在醫院和醫療機構的普及。

人們越來越關注如何提高慢性心臟疾病患者的生活品質，這也推動了市場的發展。心臟幫浦裝置被視為治療心臟衰竭的重要選擇，因為患者和醫療服務提供者都在尋求能夠延長壽命並改善日常功能的解決方案。這些裝置能夠提高患者的活動能力、緩解症狀並全面改善生活品質，這是推動其使用量增加的關鍵因素。

此外，政府的支持和監管機構對心臟幫浦設備的核准正在擴大這些救命技術的普及範圍。美國食品藥物管理局(FDA) 和歐洲藥品管理局 (EMA) 等監管機構正在擴大核准新型心臟泵設備和創新技術，使這些技術能夠更廣泛地惠及醫療服務提供者和患者。這種監管支持對於推動市場擴張和促進下一代心臟泵技術的研發至關重要。

總之，心臟幫浦設備市場的成長主要受以下因素驅動：心臟衰竭衰竭盛行率上升、技術進步、全球人口老化以及對機械循環支援需求的不斷成長。隨著醫療系統持續採用心臟泵設備作為治療進行性心臟疾病的關鍵解決方案，這些設備將在提高患者生存率、減少再入院率以及改善全球心臟衰竭患者的生活品質方面發揮日益重要的作用。

部分：

依產品（心室輔助裝置 (VAD)、主動脈內球囊反搏幫浦 (IABP)、經導管人工心臟 (TAH)）、類型（植入式、體外）及治療方法（移植過渡治療 (BTT)、移植合格治療 (BTC)、根治性治療 (DT)、其他治療方法）分類

受訪公司範例

  • Abbott Laboratories
  • Abiomed, Inc.
  • Berlin Heart GmbH
  • Fresenius Medical Care AG &Co. KGaA
  • Getinge AB
  • Jarvik Heart, Inc.
  • Medtronic PLC
  • ReliantHeart, Inc.
  • SynCardia Systems, LLC
  • Teleflex Incorporated
  • Terumo Europe NV

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具，革新市場和競爭情報分析。

Market Glass, Inc. 並沒有採用典型的 LLM 或產業專用的SLM 方法，而是建立了一個由世界各地領域專家精心策劃的內容庫，其中包括影片轉錄、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

在最新發布的報告中，Market Glass, Inc. 將關稅對地理市場的影響納入考量，並根據公司總部所在地、製造地以及進出口（成品和OEM產品）情況，預測企業競爭地位的變化。這種複雜多變的市場現實會從多個方面影響競爭對手，包括增加銷貨成本、降低盈利和重組供應鏈，同時也會影響微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 世界其他地區

第4章 競賽

簡介目錄
Product Code: MCP12313

Global Heart Pump Devices Market to Reach US$8.5 Billion by 2030

The global market for Heart Pump Devices estimated at US$3.2 Billion in the year 2024, is expected to reach US$8.5 Billion by 2030, growing at a CAGR of 17.4% over the analysis period 2024-2030. Ventricular Assist Devices (VADs), one of the segments analyzed in the report, is expected to record a 19.1% CAGR and reach US$5.1 Billion by the end of the analysis period. Growth in the Intra-aortic Balloon Pumps (IABPs) segment is estimated at 14.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$884.6 Million While China is Forecast to Grow at 16.4% CAGR

The Heart Pump Devices market in the U.S. is estimated at US$884.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 16.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.7% and 14.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.2% CAGR.

Global Heart Pump Devices Market - Key Trends and Drivers Summarized

Why Are Heart Pump Devices Becoming Essential for Treating Advanced Heart Failure, Supporting Cardiac Surgeries, and Improving Patient Survival Rates?

Heart pump devices have become essential for treating advanced heart failure, supporting cardiac surgeries, and improving patient survival rates. But why are these devices so critical today? With the rising prevalence of heart failure globally, heart pump devices, such as left ventricular assist devices (LVADs) and total artificial hearts (TAHs), are providing life-saving solutions for patients who are no longer responsive to medication or traditional therapies. These devices are crucial in assisting or completely replacing the function of a failing heart by helping it pump blood more effectively, ensuring that vital organs continue to receive sufficient oxygen and nutrients. For many patients with end-stage heart failure, heart pump devices are the only viable option to sustain life while waiting for a heart transplant or as a long-term alternative when transplants are not an option.

In addition to managing heart failure, heart pump devices play a vital role in supporting patients undergoing high-risk cardiac surgeries. In such procedures, temporary mechanical circulatory support provided by heart pump devices ensures that blood flow is maintained, reducing the risk of complications during and after surgery. These devices are also being increasingly used to stabilize patients in critical conditions, such as those recovering from heart attacks or cardiogenic shock, where the heart cannot pump enough blood on its own.

Moreover, heart pump devices significantly improve the quality of life for heart failure patients by reducing symptoms like fatigue, shortness of breath, and fluid retention. By supporting the heart’s function, these devices allow patients to engage in everyday activities with greater ease, improving both physical and mental well-being.

How Are Technological Advancements and Innovations Enhancing the Efficiency, Safety, and Longevity of Heart Pump Devices?

Technological advancements and innovations are significantly enhancing the efficiency, safety, and longevity of heart pump devices, making them more reliable and effective for patients with heart failure. One of the most impactful innovations is the development of smaller, more durable, and less invasive left ventricular assist devices (LVADs). These newer-generation LVADs are designed to be implanted with fewer surgical risks and provide better outcomes for patients. Innovations in miniaturization have allowed these devices to fit into a broader range of patients, including those who previously might not have been candidates due to the size of earlier models. These smaller devices also cause fewer complications, such as infections or blood clots, by minimizing the need for extensive surgical procedures.

Another significant advancement in heart pump technology is the improvement of energy efficiency and battery life. Earlier generations of heart pump devices required external batteries that patients had to carry with them, limiting mobility and convenience. Today, advanced battery technologies allow for longer-lasting, portable power supplies, reducing the need for frequent battery changes or recharging. Some devices are even exploring wireless charging technologies, which would eliminate the need for external power cables and further enhance the patient’s quality of life. These improvements make heart pump devices more practical and less burdensome, allowing patients to move more freely and live more independently.

The integration of artificial intelligence (AI) and data analytics is another key innovation in heart pump devices. AI-powered monitoring systems can continuously track the device's performance and the patient’s physiological parameters, detecting potential issues early and alerting healthcare providers to any signs of malfunction or deterioration. These intelligent systems help optimize device settings and make real-time adjustments to ensure the heart pump is working at peak efficiency. AI algorithms can also predict when a patient may need medical intervention, improving long-term outcomes and reducing the risk of complications.

Biocompatible materials are another area where heart pump devices are seeing significant improvements. New materials used in these devices reduce the risk of blood clotting (thrombosis) and infection, which are common complications associated with heart pumps. The use of advanced coatings and materials that mimic the body’s tissues minimizes the immune system’s response to the device, reducing the need for blood thinners and other medications. This not only enhances patient safety but also extends the longevity of the device by reducing wear and tear.

Remote monitoring capabilities are also transforming the way heart pump devices are managed. Patients with heart pumps can now be monitored remotely through connected health platforms, where healthcare providers can track device performance and patient health metrics in real-time. This allows for early detection of potential issues, reduces the frequency of in-person clinic visits, and provides peace of mind to both patients and clinicians. In addition, advancements in remote monitoring are making it easier for patients to receive personalized care and adjustments to their treatment plans without the need for frequent hospital stays.

Why Are Heart Pump Devices Critical for Reducing Hospital Readmissions, Extending Life Expectancy, and Enhancing Quality of Life for Heart Failure Patients?

Heart pump devices are critical for reducing hospital readmissions, extending life expectancy, and enhancing the quality of life for heart failure patients because they provide a long-term solution for those with severe heart conditions. One of the primary reasons heart pump devices are so valuable is their ability to reduce the frequency of hospital readmissions in patients with chronic heart failure. Heart failure is often characterized by recurring symptoms, leading to repeated hospitalizations as the heart becomes less effective at pumping blood. Heart pump devices alleviate this by consistently supporting the heart’s function, stabilizing the patient’s condition, and reducing the need for frequent medical interventions. This not only improves the patient’s quality of life but also reduces the strain on healthcare systems by lowering the demand for emergency care and hospital resources.

Extending life expectancy is another significant benefit of heart pump devices. For patients with end-stage heart failure, life expectancy is often limited to a few months or years without advanced treatment options. Heart pump devices, particularly LVADs, have been shown to significantly extend survival rates by supporting heart function while patients wait for a heart transplant or as a long-term therapy when transplantation is not feasible. In many cases, patients with LVADs can live for several years with the device, providing them with more time to receive other treatments or maintain a better quality of life.

Enhancing the quality of life for heart failure patients is a key advantage of heart pump devices. Heart failure can severely limit a patient’s ability to perform daily activities, leading to fatigue, shortness of breath, and a reduced ability to participate in physical activities. Heart pump devices help alleviate these symptoms by improving blood flow, allowing patients to regain their strength and energy. This, in turn, enables them to lead more active lives, participate in social activities, and experience a greater sense of independence. Many patients with heart pump devices report significant improvements in their physical and emotional well-being after receiving the device.

Heart pump devices also offer an alternative for patients who are not eligible for heart transplants. For various reasons, including age, comorbidities, or the availability of donor hearts, some patients may not be suitable candidates for heart transplantation. In these cases, heart pump devices serve as a long-term solution, providing mechanical support to the heart and allowing patients to live longer, healthier lives. This is particularly valuable for older patients or those with other medical conditions that complicate their candidacy for a transplant.

In addition to their role in treating heart failure, heart pump devices also help prevent complications related to other cardiovascular conditions, such as cardiogenic shock or heart attacks. By providing mechanical circulatory support during these critical events, heart pump devices can stabilize patients and prevent further damage to the heart, improving overall survival rates and reducing the risk of long-term complications.

What Factors Are Driving the Growth of the Heart Pump Devices Market?

Several key factors are driving the rapid growth of the heart pump devices market, including the increasing prevalence of heart failure, advancements in heart pump technology, the aging global population, and the rising demand for mechanical circulatory support. One of the primary drivers is the growing prevalence of heart failure worldwide. As populations age and lifestyle factors such as obesity, hypertension, and diabetes become more common, the number of individuals suffering from heart failure is steadily increasing. This has created a significant demand for advanced treatment options, such as heart pump devices, that can provide effective, long-term solutions for patients who are no longer responsive to medication or less invasive therapies.

Advancements in heart pump technology are another major factor fueling the growth of the market. The development of smaller, more durable, and less invasive devices has made heart pumps more accessible to a broader range of patients, including those with less severe heart failure or those who may not have been candidates for older-generation devices. These technological improvements have also led to better patient outcomes, fewer complications, and increased survival rates, driving the adoption of heart pump devices in healthcare systems around the world.

The aging global population is also contributing to the growth of the heart pump devices market. As life expectancy continues to rise, the incidence of age-related cardiovascular conditions, including heart failure, is increasing. Older patients are more likely to suffer from conditions that weaken the heart, making them prime candidates for heart pump devices. With the number of elderly individuals projected to grow significantly over the coming decades, the demand for heart pumps as a treatment option for age-related heart failure is expected to rise.

The rising demand for mechanical circulatory support in both short-term and long-term scenarios is another factor driving market growth. Heart pump devices are increasingly being used in critical care settings, such as during high-risk cardiac surgeries or for patients recovering from heart attacks or cardiogenic shock. The ability of heart pump devices to stabilize patients and support recovery has made them a valuable tool for cardiologists and cardiac surgeons, further driving their adoption in hospitals and healthcare facilities.

The growing focus on improving the quality of life for patients with chronic heart conditions is also propelling the market. As patients and healthcare providers seek solutions that not only extend life but also enhance day-to-day functioning, heart pump devices are being viewed as an essential option for managing heart failure. The improvements in patient mobility, reduction in symptoms, and overall better quality of life provided by these devices are significant motivators for their increasing use.

Additionally, government support and regulatory approvals for heart pump devices are expanding access to these life-saving technologies. Regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA), are increasingly approving new heart pump devices and innovations, making these technologies more widely available to healthcare providers and patients. This regulatory support is crucial for driving market expansion and fostering the development of next-generation heart pump technologies.

In conclusion, the growth of the heart pump devices market is driven by the rising prevalence of heart failure, advancements in technology, the aging global population, and the increasing demand for mechanical circulatory support. As healthcare systems continue to adopt heart pump devices as a critical solution for managing advanced heart conditions, these devices will play an increasingly vital role in improving patient survival, reducing hospital readmissions, and enhancing the quality of life for heart failure patients worldwide.

SCOPE OF STUDY:

The report analyzes the Heart Pump Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs), Total Artificial Heart (TAH)); Type (Implantable, Extracorporeal); Therapy (Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT), Other Therapies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 13 Featured) -

  • Abbott Laboratories
  • Abiomed, Inc.
  • Berlin Heart GmbH
  • Fresenius Medical Care AG & Co. KGaA
  • Getinge AB
  • Jarvik Heart, Inc.
  • Medtronic PLC
  • ReliantHeart, Inc.
  • SynCardia Systems, LLC
  • Teleflex Incorporated
  • Terumo Europe NV

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Global Economic Update
    • Heart Pump Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Cardiovascular Diseases Propels Demand for Heart Pump Devices
    • Expansion of Heart Transplant Programs Strengthens Business Case for Temporary Heart Pump Devices
    • Increasing Focus on Minimally Invasive Procedures Spurs Adoption of Percutaneous Heart Pumps
    • Growing Aging Population Expands Addressable Market Opportunity for Heart Pump Devices
    • Expansion of Chronic Heart Failure Treatment Programs Bodes Well for Market Growth
    • Future Directions: Development of Fully Implantable Artificial Hearts Accelerates Market Potential
    • Growing Popularity of Bridge-to-Transplant Therapies Expands Adoption of Heart Pumps
    • Expansion of Cardiac Centers and Specialized Clinics Generates Demand for Heart Pump Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Heart Pump Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Heart Pump Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Heart Pump Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Heart Pump Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Ventricular Assist Devices (VADs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Ventricular Assist Devices (VADs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Ventricular Assist Devices (VADs) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Intra-aortic Balloon Pumps (IABPs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Intra-aortic Balloon Pumps (IABPs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Intra-aortic Balloon Pumps (IABPs) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Total Artificial Heart (TAH) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Total Artificial Heart (TAH) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Total Artificial Heart (TAH) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Implantable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Implantable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Implantable by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Extracorporeal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Extracorporeal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Extracorporeal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Bridge-to-Transplant (BTT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Bridge-to-Transplant (BTT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Bridge-to-Transplant (BTT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Bridge-to-Candidacy (BTC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Bridge-to-Candidacy (BTC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Bridge-to-Candidacy (BTC) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Destination Therapy (DT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Destination Therapy (DT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Destination Therapy (DT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other Therapies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Heart Pump Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Heart Pump Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Heart Pump Devices by Type - Implantable and Extracorporeal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Heart Pump Devices by Type - Implantable and Extracorporeal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Heart Pump Devices by Type - Percentage Breakdown of Value Sales for Implantable and Extracorporeal for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Heart Pump Devices by Therapy - Percentage Breakdown of Value Sales for Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Heart Pump Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Heart Pump Devices by Type - Implantable and Extracorporeal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Heart Pump Devices by Type - Implantable and Extracorporeal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Heart Pump Devices by Type - Percentage Breakdown of Value Sales for Implantable and Extracorporeal for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Heart Pump Devices by Therapy - Percentage Breakdown of Value Sales for Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies for the Years 2015, 2025 & 2030
  • JAPAN
    • Heart Pump Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Heart Pump Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Heart Pump Devices by Type - Implantable and Extracorporeal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Heart Pump Devices by Type - Implantable and Extracorporeal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Heart Pump Devices by Type - Percentage Breakdown of Value Sales for Implantable and Extracorporeal for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Heart Pump Devices by Therapy - Percentage Breakdown of Value Sales for Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies for the Years 2015, 2025 & 2030
  • CHINA
    • Heart Pump Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Heart Pump Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Heart Pump Devices by Type - Implantable and Extracorporeal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Heart Pump Devices by Type - Implantable and Extracorporeal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Heart Pump Devices by Type - Percentage Breakdown of Value Sales for Implantable and Extracorporeal for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Heart Pump Devices by Therapy - Percentage Breakdown of Value Sales for Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies for the Years 2015, 2025 & 2030
  • EUROPE
    • Heart Pump Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Heart Pump Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Heart Pump Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Heart Pump Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Heart Pump Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Heart Pump Devices by Type - Implantable and Extracorporeal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Heart Pump Devices by Type - Implantable and Extracorporeal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Heart Pump Devices by Type - Percentage Breakdown of Value Sales for Implantable and Extracorporeal for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Heart Pump Devices by Therapy - Percentage Breakdown of Value Sales for Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies for the Years 2015, 2025 & 2030
  • FRANCE
    • Heart Pump Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Heart Pump Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Heart Pump Devices by Type - Implantable and Extracorporeal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Heart Pump Devices by Type - Implantable and Extracorporeal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Heart Pump Devices by Type - Percentage Breakdown of Value Sales for Implantable and Extracorporeal for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Heart Pump Devices by Therapy - Percentage Breakdown of Value Sales for Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies for the Years 2015, 2025 & 2030
  • GERMANY
    • Heart Pump Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Heart Pump Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Heart Pump Devices by Type - Implantable and Extracorporeal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Heart Pump Devices by Type - Implantable and Extracorporeal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Heart Pump Devices by Type - Percentage Breakdown of Value Sales for Implantable and Extracorporeal for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Heart Pump Devices by Therapy - Percentage Breakdown of Value Sales for Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Heart Pump Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Heart Pump Devices by Type - Implantable and Extracorporeal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Heart Pump Devices by Type - Implantable and Extracorporeal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Heart Pump Devices by Type - Percentage Breakdown of Value Sales for Implantable and Extracorporeal for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Heart Pump Devices by Therapy - Percentage Breakdown of Value Sales for Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Heart Pump Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Heart Pump Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Heart Pump Devices by Type - Implantable and Extracorporeal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Heart Pump Devices by Type - Implantable and Extracorporeal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Heart Pump Devices by Type - Percentage Breakdown of Value Sales for Implantable and Extracorporeal for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Heart Pump Devices by Therapy - Percentage Breakdown of Value Sales for Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Rest of Europe 15-Year Perspective for Heart Pump Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) for the Years 2015, 2025 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Heart Pump Devices by Type - Implantable and Extracorporeal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Heart Pump Devices by Type - Implantable and Extracorporeal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Europe 15-Year Perspective for Heart Pump Devices by Type - Percentage Breakdown of Value Sales for Implantable and Extracorporeal for the Years 2015, 2025 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Europe 15-Year Perspective for Heart Pump Devices by Therapy - Percentage Breakdown of Value Sales for Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Heart Pump Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Asia-Pacific 15-Year Perspective for Heart Pump Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) for the Years 2015, 2025 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Heart Pump Devices by Type - Implantable and Extracorporeal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Heart Pump Devices by Type - Implantable and Extracorporeal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Asia-Pacific 15-Year Perspective for Heart Pump Devices by Type - Percentage Breakdown of Value Sales for Implantable and Extracorporeal for the Years 2015, 2025 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Asia-Pacific 15-Year Perspective for Heart Pump Devices by Therapy - Percentage Breakdown of Value Sales for Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for Heart Pump Devices by Product - Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of World 15-Year Perspective for Heart Pump Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs) and Total Artificial Heart (TAH) for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Heart Pump Devices by Type - Implantable and Extracorporeal - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Heart Pump Devices by Type - Implantable and Extracorporeal Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of World 15-Year Perspective for Heart Pump Devices by Type - Percentage Breakdown of Value Sales for Implantable and Extracorporeal for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Heart Pump Devices by Therapy - Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of World 15-Year Perspective for Heart Pump Devices by Therapy - Percentage Breakdown of Value Sales for Bridge-to-Transplant (BTT), Bridge-to-Candidacy (BTC), Destination Therapy (DT) and Other Therapies for the Years 2015, 2025 & 2030

IV. COMPETITION